Strata Skin Sciences Net Profit Margin 2011-2025 | SSKN
Strata Skin Sciences net profit margin from 2011 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Strata Skin Sciences Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-09-30 | $0.03B | $-0.01B | -34.38% |
| 2025-06-30 | $0.03B | $-0.01B | -32.35% |
| 2025-03-31 | $0.03B | $-0.01B | -26.47% |
| 2024-12-31 | $0.03B | $-0.01B | -29.41% |
| 2024-09-30 | $0.03B | $-0.01B | -27.27% |
| 2024-06-30 | $0.03B | $-0.01B | -24.24% |
| 2024-03-31 | $0.03B | $-0.01B | -33.33% |
| 2023-12-31 | $0.03B | $-0.01B | -32.35% |
| 2023-09-30 | $0.04B | $-0.01B | -19.44% |
| 2023-06-30 | $0.04B | $-0.01B | -19.44% |
| 2023-03-31 | $0.04B | $-0.01B | -16.22% |
| 2022-12-31 | $0.04B | $-0.01B | -16.67% |
| 2022-09-30 | $0.03B | $-0.01B | -20.59% |
| 2022-06-30 | $0.03B | $-0.01B | -21.21% |
| 2022-03-31 | $0.03B | $0.00B | -12.90% |
| 2021-12-31 | $0.03B | $0.00B | -10.00% |
| 2021-09-30 | $0.03B | $0.00B | -7.14% |
| 2021-06-30 | $0.03B | $0.00B | -7.69% |
| 2021-03-31 | $0.02B | $-0.01B | -21.74% |
| 2020-12-31 | $0.02B | $0.00B | -16.67% |
| 2020-09-30 | $0.03B | $-0.01B | -19.23% |
| 2020-06-30 | $0.03B | $-0.01B | -18.52% |
| 2020-03-31 | $0.03B | $0.00B | -12.90% |
| 2019-12-31 | $0.03B | $0.00B | -12.90% |
| 2019-09-30 | $0.03B | $0.00B | -10.00% |
| 2019-06-30 | $0.03B | $0.00B | -9.68% |
| 2019-03-31 | $0.03B | $0.00B | -10.00% |
| 2018-12-31 | $0.03B | $0.00B | -13.33% |
| 2018-09-30 | $0.03B | $-0.01B | -25.81% |
| 2018-06-30 | $0.03B | $-0.02B | -70.00% |
| 2018-03-31 | $0.03B | $-0.02B | -67.74% |
| 2017-12-31 | $0.03B | $-0.02B | -67.74% |
| 2017-09-30 | $0.03B | $-0.02B | -60.00% |
| 2017-06-30 | $0.03B | $-0.01B | -19.35% |
| 2017-03-31 | $0.03B | $-0.01B | -16.13% |
| 2016-12-31 | $0.03B | $0.00B | -12.50% |
| 2016-09-30 | $0.03B | $0.00B | -12.12% |
| 2016-06-30 | $0.03B | $-0.01B | -42.42% |
| 2016-03-31 | $0.03B | $-0.02B | -84.62% |
| 2015-12-31 | $0.02B | $-0.03B | -155.56% |
| 2015-09-30 | $0.01B | $-0.03B | -366.67% |
| 2015-06-30 | $0.00B | $-0.02B | -2300.00% |
| 2015-03-31 | $0.00B | $-0.01B | 0.00% |
| 2014-12-31 | $0.00B | $-0.02B | 0.00% |
| 2014-09-30 | $0.00B | $-0.01B | 0.00% |
| 2014-06-30 | $0.00B | $-0.02B | 0.00% |
| 2014-03-31 | $0.00B | $-0.03B | 0.00% |
| 2013-12-31 | $0.00B | $-0.03B | 0.00% |
| 2013-09-30 | $0.00B | $-0.03B | 0.00% |
| 2013-06-30 | $0.00B | $-0.03B | 0.00% |
| 2013-03-31 | $0.00B | $-0.02B | 0.00% |
| 2012-12-31 | $0.00B | $-0.02B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.009B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.404B | 55.40 |
| Tempus AI (TEM) | United States | $11.811B | 0.00 |
| Doximity (DOCS) | United States | $8.862B | 36.49 |
| Hims & Hers Health (HIMS) | United States | $8.100B | 65.89 |
| IRhythm Technologies (IRTC) | United States | $5.397B | 0.00 |
| Hinge Health (HNGE) | United States | $3.215B | 0.00 |
| Privia Health (PRVA) | United States | $2.856B | 178.62 |
| Inspire Medical Systems (INSP) | United States | $2.466B | 40.80 |
| Heartflow (HTFL) | United States | $2.248B | 0.00 |
| 10x Genomics (TXG) | United States | $1.987B | 0.00 |
| Enovis (ENOV) | United States | $1.618B | 8.50 |
| Omnicell (OMCL) | United States | $1.534B | 31.37 |
| Azenta (AZTA) | United States | $1.346B | 58.74 |
| Schrodinger (SDGR) | United States | $1.286B | 0.00 |
| Phreesia (PHR) | United States | $1.234B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.214B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.891B | 0.00 |
| Claritev (CTEV) | United States | $0.630B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 106.00 |
| Veradigm (MDRX) | United States | $0.517B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.498B | 0.00 |
| Standard BioTools (LAB) | United States | $0.465B | 0.00 |
| Evolent Health (EVH) | United States | $0.432B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| Carlsmed (CARL) | United States | $0.327B | 0.00 |
| TruBridge (TBRG) | United States | $0.308B | 14.15 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.274B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.256B | 0.00 |
| CapsoVision (CV) | United States | $0.248B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.208B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.192B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.162B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.158B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.152B | 0.00 |
| CareCloud (CCLD) | United States | $0.132B | 7.23 |
| EUDA Health Holdings (EUDA) | Singapore | $0.103B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| Pulmonx (LUNG) | United States | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.043B | 0.00 |
| Precipio (PRPO) | United States | $0.037B | 0.00 |
| 111 (YI) | China | $0.034B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |